Serine

fibrinogen beta chain ; Homo sapiens







38 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 33411219 Thrombin generation and activity in multiple sclerosis. 2021 Mar 1
2 33815366 A Clot Twist: Extreme Variation in Coagulotoxicity Mechanisms in Mexican Neotropical Rattlesnake Venoms. 2021 1
3 34169424 Development and Validation of a Simoa Assay for Determination of Recombinant Batroxobin in Human Serum. 2021 Jun 1
4 27221710 Platelets contribute to amyloid-β aggregation in cerebral vessels through integrin αIIbβ3-induced outside-in signaling and clusterin release. 2016 May 24 1
5 25330904 The β isoform of the catalytic subunit of protein phosphatase 2B restrains platelet function by suppressing outside-in αII b β3 integrin signaling. 2014 Dec 1
6 23717569 Role of the serine-rich surface glycoprotein Srr1 of Streptococcus agalactiae in the pathogenesis of infective endocarditis. 2013 1
7 17559410 Peptidase profiles from non-albicans Candida spp. isolated from the blood of a patient with chronic myeloid leukemia and another with sickle cell disease. 2007 Sep 1
8 17885889 Association of CD2 with fibrinogen in human plasma: depletion of the soluble E-receptor in blood clotting. 2007 2
9 16406498 Fibrinogen Guarenas, an abnormal fibrinogen with an Aalpha-chain truncation due to a nonsense mutation at Aalpha 467 Glu (GAA)-->stop (TAA). 2006 1
10 16607083 Novel fibrinogen mutation (gamma 313 Ser-->Asn) associated with hypofibrinogenemia in two unrelated families. 2006 Jan 1
11 15601711 Molecular diversity of a putative virulence factor: purification and characterization of isoforms of an extracellular serine glutamyl endopeptidase of Enterococcus faecalis with different enzymatic activities. 2005 Jan 1
12 15632207 Fibrinogen Philadelphia, a hypodysfibrinogenemia characterized by abnormal polymerization and fibrinogen hypercatabolism due to gamma S378P mutation. 2005 Apr 15 1
13 15007078 Molecular and functional differences induced in thrombospondin-1 by the single nucleotide polymorphism associated with the risk of premature, familial myocardial infarction. 2004 May 14 2
14 15166913 Biophysical characterization of fibrinogen Caracas I with an Aalpha-chain truncation at Aalpha-466 Ser: identification of the mutation and biophysical characterization of properties of clots from plasma and purified fibrinogen. 2004 Jun 1
15 12729597 Stable isotope phospho-profiling of fibrinogen and fetuin subunits by element mass spectrometry coupled to capillary liquid chromatography. 2003 Jun 1 2
16 12062406 Involvement of fibrinogen specific binding in erythrocyte aggregation. 2002 Apr 24 2
17 10946093 Thrombotic dysfibrinogenemia. Fibrinogen "Caracas V" relation between very tight fibrin network and defective clot degradability. 2000 Jul 15 3
18 10572095 Fibrinogen Niigata with impaired fibrin assembly: an inherited dysfibrinogen with a Bbeta Asn-160 to Ser substitution associated with extra glycosylation at Bbeta Asn-158. 1999 Dec 1 1
19 9630497 Role of the gamma chain Ala-Gly-Asp-Val and Aalpha chain Arg-Gly-Asp-Ser sites of fibrinogen in coaggregation of platelets and fibrinogen-coated beads. 1998 Jun 11 2
20 8883274 Normal binding of calcium to five fibrinogen variants with mutations in the carboxy terminal part of the gamma-chain. 1996 Sep 1
21 8276866 Role of interchain disulfide bonds on the assembly and secretion of human fibrinogen. 1994 Jan 7 1
22 1328443 Analysis of the heterogeneity of the biological responses to native and mutant human interleukin-6. 1992 Oct 1
23 1920361 Development of a small RGD peptide fibrinogen receptor antagonist with potent antiaggregatory activity in vitro. 1991 Oct 1
24 2573600 Transglutaminase-mediated cross-linking of fibrinogen by human umbilical vein endothelial cells. 1989 Dec 5 2
25 2613766 Fibrinogen-mediated epidermal cell migration: structural correlates for fibrinogen function. 1989 Sep 1
26 2773809 Immunogold-surface replica study of ADP-induced ligand binding and fibrinogen receptor clustering in human platelets. 1989 Jun-Jul 1
27 2460346 Anti-(Arg-Gly-Asp-Ser) antibody and its interaction with fibronectin, fibrinogen and platelets. 1988 Oct 15 1
28 3036276 Arginyl-glycyl-aspartic acid sequences and fibrinogen binding to platelets. 1987 Jul 1
29 3101598 Phosphorylation of human fibrinogen in vitro with protein kinase C: characterization of the phosphorylated sites. 1987 Jan 1
30 3584243 The platelet fibrinogen receptor: an immunogold-surface replica study of agonist-induced ligand binding and receptor clustering. 1987 Jun 1
31 3603434 Increase in the degree of phosphorylation of circulating fibrinogen under thrombolytic therapy with urokinase. 1987 May 1 2
32 3814824 The synthetic RGDS peptide inhibits the binding of fibrinogen lacking intact alpha chain carboxyterminal sequences to human blood platelets. 1987 Mar 1
33 2995350 The tetrapeptide analogue of the cell attachment site of fibronectin inhibits platelet aggregation and fibrinogen binding to activated platelets. 1985 Oct 5 1
34 3876125 Inhibition of platelet adhesion to fibronectin, fibrinogen, and von Willebrand factor substrates by a synthetic tetrapeptide derived from the cell-binding domain of fibronectin. 1985 Oct 1
35 6238619 Comparison of structures of various human fibrinogens and a derivative thereof by a study of the kinetics of release of fibrinopeptides. 1984 Sep 25 1
36 6719396 The location of a second in vivo phosphorylation site in the A alpha-chain of human fibrinogen. 1984 Mar 1 1
37 505412 An acquired abnormal fibrinogen associated with thromboembolic disease and pseudotumor cerebri. 1979 Oct 31 1
38 277910 Synthetic peptide derivatives that bind to fibrinogen and prevent the polymerization of fibrin monomers. 1978 Jul 1